Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Heffernan Michael Thomas Create: Alert

All | News | Filings
Date FiledTypeDescription
06/30/2023 4 Heffernan Michael Thomas (Director) has filed a Form 4 on Trevi Therapeutics, Inc.
Txns: Granted 30,000 options to buy @ $2.27, valued at $68.1k
05/19/2023 4 Heffernan Michael Thomas (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns: Granted 9,792 shares @ $0
05/04/2023 4 Heffernan Michael Thomas (Director) has filed a Form 4 on Biohaven Ltd.
Txns: Granted 52,906 options to buy @ $13.2, valued at $698.4k
12/27/2022 4 Heffernan Michael Thomas (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns: Sold 237 shares @ $23, valued at $5.5k
Sold 4,989 shares @ $23, valued at $114.7k
Sold 15,995 shares @ $23.63, valued at $378k
Sold 3,820 shares @ $24.16, valued at $92.3k
Exercised 237 options to buy @ $16.15, valued at $3.8k
Exercised 4,989 options to buy @ $16.15, valued at $80.6k
Exercised 15,995 options to buy @ $16.15, valued at $258.3k
Exercised 3,820 options to buy @ $16.15, valued at $61.7k
12/21/2022 4 Heffernan Michael Thomas (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns: Sold 3,606 shares @ $23.04, valued at $83.1k
Sold 33,758 shares @ $23.08, valued at $779.1k
Sold 46,600 shares @ $23.11, valued at $1.1M
Exercised 3,606 options to buy @ $16.15, valued at $58.2k
Exercised 33,758 options to buy @ $16.15, valued at $545.2k
Exercised 46,600 options to buy @ $16.15, valued at $752.6k
12/14/2022 4 Heffernan Michael Thomas (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns: Sold 27,920 shares @ $22.01, valued at $614.5k
Sold 161,687 shares @ $22.16, valued at $3.6M
Exercised 10,669 options to buy @ $14.9, valued at $159k
Exercised 15,741 options to buy @ $15.27, valued at $240.4k
Exercised 1,510 options to buy @ $14.57, valued at $22k
Exercised 59,524 options to buy @ $14.9, valued at $886.9k
Exercised 94,259 options to buy @ $15.27, valued at $1.4M
Exercised 7,904 options to buy @ $14.57, valued at $115.2k
10/12/2022 4/A Heffernan Michael Thomas (Director) has filed a Form 4 on Biohaven Ltd.
Txns: Paid exercise price by delivering 9,699 shares @ $7.5, valued at $72.7k
10/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/30/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
07/01/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
06/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/13/2022 4 Heffernan Michael Thomas (Director) has filed a Form 4 on SYNLOGIC, INC.
Txns: Granted 27,000 options to buy @ $1.17, valued at $31.6k
05/23/2022 4 Heffernan Michael Thomas (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns: Granted 14,035 shares @ $0
04/29/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/22/2021 4 Heffernan Michael Thomas (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.
Txns: Granted 3,320 options to buy @ $0
06/17/2021 4 Heffernan Michael Thomas (Director) has filed a Form 4 on Trevi Therapeutics, Inc.
Txns: Granted 20,000 options to buy @ $2.25, valued at $45k
06/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/24/2021 4 Heffernan Michael Thomas (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns: Granted 9,941 shares @ $0
05/07/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/26/2021 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
03/17/2021 4 Heffernan Michael Thomas (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns: Sold 47,044 shares @ $25.26, valued at $1.2M
Sold 3,031 shares @ $25.88, valued at $78.4k
12/09/2020 4 Heffernan Michael Thomas (Director) has filed a Form 4 on SYNLOGIC, INC.
Txns: Granted 30,000 options to buy @ $2.29, valued at $68.7k
12/09/2020 3 Heffernan Michael Thomas (Director) has filed a Form 3 on SYNLOGIC, INC.
08/12/2020 4 Heffernan Michael Thomas (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns: Sold 13,071 shares @ $19.13, valued at $250k
06/15/2020 4 Heffernan Michael Thomas (Director) has filed a Form 4 on Trevi Therapeutics, Inc.
Txns: Granted 14,210 options to buy @ $4.1, valued at $58.3k
06/09/2020 4 Heffernan Michael Thomas (Director) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Granted 13,700 shares @ $0
Granted 20,100 options to buy @ $11.96, valued at $240.4k
05/22/2020 4 Heffernan Michael Thomas (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns: Paid exercise price by delivering 18,650 shares @ $22.05, valued at $411.2k
Granted 4,047 shares @ $0
Granted 8,095 options to buy @ $22.05, valued at $178.5k
05/15/2020 4 Heffernan Michael Thomas (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns: Sold 1,380 shares @ $20.92, valued at $28.9k
Sold 11,969 shares @ $21.21, valued at $253.9k
Sold 5,905 shares @ $22.64, valued at $133.7k
05/01/2020 4 Heffernan Michael Thomas (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.
Txns: Granted 18,000 options to buy @ $47.1, valued at $847.8k
02/12/2020 4 Heffernan Michael Thomas (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns: Paid exercise price by delivering 4,962 shares @ $21.62, valued at $107.3k
01/31/2020 4 Heffernan Michael Thomas (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.
Txns: Granted 36,000 options to buy @ $48.49, valued at $1.7M
01/31/2020 3 Heffernan Michael Thomas (Director) has filed a Form 3 on Biohaven Pharmaceutical Holding Co Ltd.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy